News & Events
Oraya Therapeutics INTREPID Study Demonstrates Two-year Safety and Effectiveness of Non-invasive Therapy for Wet AMD
26 September 2013
Professor Usha Chakravarthy of the Centre for Vision and Vascular Science is giving a talk at EURETINA 2013 in Hamburg, Germany on Friday 27 September 2013. Prof Chakravarthy’s talk, “Characteristics of radiation induced microangiopathy in the treatment of wet AMD” is one of several given by key members of the INTREPID group as the two-year results of their study of Oraya Therapy™ Stereotactic Radiotherapy are announced. The results show continued evidence of the therapy’s ability to reduce the frequency of VEGF injections into the eye for suitable patients, lowering the cost of treatment of Wet AMD.
Read the full press release from Oraya Therapeutics here.